Grown Rogue International (GRUSF) Free Cash Flow Growth (1y) (2014 - 2026)
Grown Rogue International (GRUSF) Free Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 44.93% |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn | 102.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.57% |
| Dec 31, 2025 | -85,066,906.27% |
| Sep 30, 2025 | 86,248,785.29% |
| Jun 30, 2025 | -47.03% |
| Mar 31, 2025 | -166.96% |
| Dec 31, 2024 | 1,294.41% |
| Jan 31, 2023 | 6.86% |
| Jan 31, 2022 | 124.73% |
| Oct 31, 2021 | 124,440,112.34% |
| Jul 31, 2021 | 33.09% |
| Apr 30, 2021 | 136.66% |
| Jan 31, 2021 | 93.63% |
| Oct 31, 2020 | 94.08% |
| Jul 31, 2020 | -118.16% |
| Apr 30, 2020 | 825.58% |
| Jan 31, 2020 | 106.98% |
| Oct 31, 2019 | -283.76% |
| Jul 31, 2019 | 941.35% |
| Apr 30, 2019 | 106.91% |
| Jan 31, 2019 | -938.47% |